261 related articles for article (PubMed ID: 19307982)
1. Long-term decline in renal function is linked to initial pulse pressure in the essential hypertensive.
Gosse P; Coulon P; Papaioannou G; Litalien J; Lemetayer P
J Hypertens; 2009 Jun; 27(6):1303-8. PubMed ID: 19307982
[TBL] [Abstract][Full Text] [Related]
2. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
3. Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension.
Fesler P; Safar ME; du Cailar G; Ribstein J; Mimran A
J Hypertens; 2007 Sep; 25(9):1915-20. PubMed ID: 17762657
[TBL] [Abstract][Full Text] [Related]
4. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
Imai E; Horio M; Yamagata K; Iseki K; Hara S; Ura N; Kiyohara Y; Makino H; Hishida A; Matsuo S
Hypertens Res; 2008 Mar; 31(3):433-41. PubMed ID: 18497462
[TBL] [Abstract][Full Text] [Related]
5. Association of renal function with the ambulatory arterial stiffness index and pulse pressure in hypertensive patients.
Wang Y; Hu Y; Li Y; Li H; Chu S; Zhu D; Gao P
Hypertens Res; 2012 Feb; 35(2):201-6. PubMed ID: 22011684
[TBL] [Abstract][Full Text] [Related]
6. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
[TBL] [Abstract][Full Text] [Related]
7. Proteinuria, renal impairment, metabolic control, and blood pressure in type 2 diabetes mellitus. A 14-year follow-up report on 195 patients.
Ravid M; Savin H; Lang R; Jutrin I; Shoshana L; Lishner M
Arch Intern Med; 1992 Jun; 152(6):1225-9. PubMed ID: 1599351
[TBL] [Abstract][Full Text] [Related]
8. Long-term renal function in primary hypertension. An epidemiological and pathophysiological study.
Siewert-Delle A
Scand J Urol Nephrol Suppl; 1999; 199():1-36. PubMed ID: 10349677
[TBL] [Abstract][Full Text] [Related]
9. Pulse pressure and mortality in hypertensive type 2 diabetic patients. A cohort study.
Mannucci E; Lambertucci L; Monami M; Fedeli A; Chiasserini V; Marchionni N; Masotti G; Ungar A
Diabetes Metab Res Rev; 2006; 22(3):172-5. PubMed ID: 16270376
[TBL] [Abstract][Full Text] [Related]
10. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
Astrup AS; Nielsen FS; Rossing P; Ali S; Kastrup J; Smidt UM; Parving HH
J Hypertens; 2007 Dec; 25(12):2479-85. PubMed ID: 17984670
[TBL] [Abstract][Full Text] [Related]
11. Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease.
Chue CD; Edwards NC; Davis LJ; Steeds RP; Townend JN; Ferro CJ
Nephrol Dial Transplant; 2011 Aug; 26(8):2576-82. PubMed ID: 21248296
[TBL] [Abstract][Full Text] [Related]
12. Relationship between arterial hypertension and renal damage in chronic kidney disease: insights from ABPM.
Paoletti E; Bellino D; Amidone M; Rolla D; Cannella G
J Nephrol; 2006; 19(6):778-82. PubMed ID: 17173252
[TBL] [Abstract][Full Text] [Related]
13. Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus.
Orth SR; Schroeder T; Ritz E; Ferrari P
Nephrol Dial Transplant; 2005 Nov; 20(11):2414-9. PubMed ID: 16046507
[TBL] [Abstract][Full Text] [Related]
14. [The kidney as a target organ in diabetic patients with arterial hypertension].
Viberti G
Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
[TBL] [Abstract][Full Text] [Related]
15. [Renal function and cardiovascular risk in patients with essential hypertension. The "FRESHA" study].
Herrero P; Marín R; Fernández Vega F; Gorostidi M; Riesgo A; Vázquez J; Díez Ojeda B;
Nefrologia; 2006; 26(3):330-8. PubMed ID: 16892821
[TBL] [Abstract][Full Text] [Related]
16. Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.
Ozturk S; Sar F; Bengi-Bozkurt O; Kazancioglu R
Kidney Blood Press Res; 2009; 32(4):268-75. PubMed ID: 19776644
[TBL] [Abstract][Full Text] [Related]
17. Relationship of metabolic syndrome with pulse pressure in patients with essential hypertension.
Mulè G; Nardi E; Cottone S; Cusimano P; Incalcaterra F; Palermo A; Giandalia ME; Mezzatesta G; Andronico G; Cerasola G
Am J Hypertens; 2007 Feb; 20(2):197-203. PubMed ID: 17261467
[TBL] [Abstract][Full Text] [Related]
18. Twelve shifting paradigms in diabetic renal disease and hypertension.
Mogensen CE
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
[TBL] [Abstract][Full Text] [Related]
19. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.
Hsu CY; McCulloch CE; Darbinian J; Go AS; Iribarren C
Arch Intern Med; 2005 Apr; 165(8):923-8. PubMed ID: 15851645
[TBL] [Abstract][Full Text] [Related]
20. Concomitant macro and microvascular complications in diabetic nephropathy.
Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
